# Ovira

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/ovira

- Industry: Medical Devices & Equipment
- Headquarters: Melbourne, Australia
- Website: www.ovira.com
- Total disclosed funding: $1.1M
- Latest round: Seed (Dec 21, 2019)
- Investors on record: 5

## About

Ovira is a company focused on developing science-backed supplements that aim to improve women's gut and hormone health through targeted solutions for common health concerns.Founded by Alice Williams in Melbourne, Australia, Ovira specializes in supplements designed to enhance women's health. The company has not undergone significant pivots or changes in its core operations since its inception. In December 2019, Ovira raised AUD 1.56 mn in Seed funding led by Blackbird, with participation from multiple investors. The company has been positioned for growth with a current valuation of AUD 6.48 mn.Ovira specializes in science-backed supplements designed to enhance women's gut and hormone health. Their core product offerings include vitamins aimed at curbing cravings, controlling bloating, and promoting clearer skin, all formulated with a focus on ingredient potency and absorption. These products target common concerns faced by women, providing effective solutions to improve overall well-being. Ovira's customer base primarily consists of health-conscious women seeking natural remedies for hormonal and digestive health issues, marketing its products across various geographical regions, including the United States and other international markets.Ovira generates revenue through direct-to-consumer sales of its supplements, which are available for purchase on their e-commerce platform. Customers can benefit from promotional offers such as a 10% discount for signing up for their newsletter. The company operates on a straightforward transaction structure, where consumers pay for individual products at set prices. Revenue is boosted by free shipping for orders over AUD 50, encouraging larger purchases and repeat business from satisfied customers.Ovira plans to leverage its recent Seed funding of AUD 1.56 mn, raised in December 2019, to support the design and launch of new product lines specifically targeting women's health issues. The company aims to expand its market presence into Europe and Asia by 2022, increasing accessibility for a broader audience. Additionally, the funding will be utilized to enhance marketing strategies to better connect with target demographics and improve overall brand visibility.

## Funding rounds

- Seed, Dec 21, 2019, $1.1M — Blackbird, Hows Your Father Pty Ltd, Dropbear Fund Pty Ltd, Gar Williams Pty Ltd, Startmate Blue Moon Pty Ltd

## Investors

- Blackbird (https://capitalatlas.ai/funds/blackbird) — Seed
- Hows Your Father Pty Ltd — Seed
- Dropbear Fund Pty Ltd — Seed
- Gar Williams Pty Ltd — Seed
- Startmate Blue Moon Pty Ltd — Seed